Herbas VPB

Print
EN | LT
LT - Endotelino ir angiotenzino II receptorių bifenilsulfonamido antagonistai, skirti glomerulosklerozės gydymui
EN - A BIPHENYLSULFONAMIDE ENDOTHELIN AND ANGIOTENSIN II RECEPTOR ANTAGONIST TO TREAT GLOMERULOSCLEROSIS

Legal status

Patent in force

Claims | Licences
Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 31/422 (2006.01)
A61P 9/12 (2006.01)
A61K 9/20 (2006.01)
A61P 13/12 (2006.01)
C07D 413/12 (2006.01)
European patent
(11) Number of the document 2732818
(13) Kind of document T
(96) European patent application number 14155459.2
Date of filing the European patent application 2010-03-29
(97) Date of publication of the European application 2014-05-21
(45) Date of publication and mention of the grant of the patent 2017-05-03
(46) Date of publication of the claims translation 2017-09-25
Priority applications
(30) Number Date Country code
165419 P 2009-03-31 US
165447 P 2009-03-31 US
Inventors
(72)
Zhang, Jinkun, US
Dziewanowska, Zofia E, US
Belder, Rene, US
Henderson, Ian, US
Bogardus, Joseph B, US
Zhang, Zhaoying, US
Grantee
(73) Ligand Pharmaceuticals Inc., 3911 Sorrento Valley Boulevard Suite 110, San Diego, CA 92121, US
Attorney or representative
(74) Jurga PETNIŪNAITĖ, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Title
(54) Endotelino ir angiotenzino II receptorių bifenilsulfonamido antagonistai, skirti glomerulosklerozės gydymui
  A BIPHENYLSULFONAMIDE ENDOTHELIN AND ANGIOTENSIN II RECEPTOR ANTAGONIST TO TREAT GLOMERULOSCLEROSIS
Last renewal fee
Payment date Validity (years) Amount
2025-03-04 16 347.00 EUR
Next renewal fee
2026-03-29
Last update date 2025-03-06